Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-24-304

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-24-304

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-24-304Grants.gov
Related Grants
HealthUpcoming
Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) Research
Varies
Health● Open
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trial
Varies
23 Dec 2027(447d)
Health● Open
DoW Toxic Exposures Clinical Trial Award
Varies
19 Nov 2026(48d)
HealthUpcoming
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
Varies
Funding Amount
Varies
USD
Application Deadline
14 October 2026
12 days remaining
Opens: 10 Oct 2024
Apply Now
Programme Details
Programme Code
PAR-24-304